Regarding prostate cancer, isoflavones, in addition to affecting the estrogen receptor, also modulate the androgen receptor, resulting in a decreased risk of the carcinogenesis process, but the detailed signalling pathways are still unknown [5]. The gene discussed is ESR1; the disease is prostate carcinoma.